{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:22:19Z","timestamp":1791516139344,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.urolonc.2025.07.007","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:21:24Z","timestamp":1754407284000},"page":"660.e11-660.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Repeat TURBT for Ta and T1 bladder cancer: An updated review"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-0268","authenticated-orcid":false,"given":"Matthew","family":"DeSanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Campanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Deem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.07.007_bib0001","unstructured":"Cancer stat facts: bladder Cancer. 2022. Accessed July 20, 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html"},{"issue":"8","key":"10.1016\/j.urolonc.2025.07.007_bib0002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5489\/cuaj.5039","article-title":"Recurrence and upstaging rates of T1 high-grade urothelial carcinoma of the bladder on repeat resection in a Canadian, resource-limited, healthcare system","volume":"12","author":"Kinnaird","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2025.07.007_bib0003","series-title":"Milken Institute 2016 report on bladder cancer","author":"Curtis","year":"2016"},{"issue":"2","key":"10.1016\/j.urolonc.2025.07.007_bib0004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.07.007_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 Amendment","volume":"211","author":"Chang","year":"2024","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.007_bib0006","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.07.007_bib0007","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/bju.15622","article-title":"Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness study","volume":"129","author":"Wettstein","year":"2022","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2025.07.007_bib0008","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non\u2013muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.07.007_bib0009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/21681805.2017.1303846","article-title":"Second-look resection for primary stage T1 bladder cancer: a population-based study","volume":"51","author":"Patschan","year":"2017","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urolonc.2025.07.007_bib0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.6004\/jnccn.2015.0123","article-title":"Role of repeat resection in non\u2013muscle-invasive bladder cancer","volume":"2015","author":"Herr","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.urolonc.2025.07.007_bib0011","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/cancers15072055","article-title":"Comparison of pathological outcome and recurrence rate between en bloc transurethral resection of bladder tumor and conventional transurethral resection: a meta-analysis","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"issue":"Suppl 4","key":"10.1016\/j.urolonc.2025.07.007_bib0012","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bju.13265","article-title":"Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series","volume":"117","author":"Gendy","year":"2016","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2025.07.007_bib0013","first-page":"407","article-title":"Racial differences in the distribution of bladder cancer metastases: a population-based analysis","volume":"73","author":"Rosiello","year":"2020","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.urolonc.2025.07.007_bib0014","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.3390\/cancers13174378","article-title":"Performance of narrow band imaging (NBI) and photodynamic diagnosis (PDD) fluorescence imaging compared to white light cystoscopy (WLC) in detecting non-muscle invasive bladder cancer: a systematic review and lesion-level diagnostic meta-analysis","author":"Russo","year":"2021","journal-title":"Cancers"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:14:17Z","timestamp":1759299257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925002571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1078143925002571"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeat TURBT for Ta and T1 bladder cancer: An updated review","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}